Skip to content

Site Navigation

Exclusive Sponsored

PB Conference Learning Gallery

Search

Latest Stories

Start your day right!

Get the latest updates and insights delivered to your inbox

Enter your email

Exclusive Sponsored

PB Conference Learning Gallery

Advertise With Us Terms & Conditions Privacy Policy Cookie Policy Contact About Us Newsletter Subsciption Subscribe

Follow us

Home
ipsen

ipsen

NICE approves elafibranor for treatment of rare liver disease

NICE approves elafibranor for treatment of rare liver disease

Longjam.dineshwori

Oct 22, 2024

Ipsen obtains development and commercial rights to mesdopetam

pharmacy.biz Staff

19 July 2021

Steven Hildemann to take over as Ipsen's chief medical officer

pharmacy.biz Staff

15 January 2020

Recent

load more

Advertise With Us Terms & Conditions Privacy Policy Cookie Policy Contact About Us Newsletter Subsciption Subscribe

© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc